Related Experiment Video
Updated: Jun 5, 2025
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Genomic tumor evolution dictates human medulloblastoma progression
Yana Ruchiy1, Ioanna Tsea1, Efthalia Preka1
1Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Background:
Medulloblastoma (MB) is the most common high-grade pediatric brain tumor, comprised of 4 main molecular subgroups-sonic-hedgehog (SHH), Wnt, Group 3, and Group 4. Group 3 and Group 4 tumors are the least characterized MB subgroups, despite Group 3 having the worst prognosis (~50% survival rate), and Group 4 being the most prevalent. Such poor characterization can be attributed to high levels of inter- and intratumoral heterogeneity, making it difficult to identify common therapeutic targets.
Methods:
In this study, we generated single-cell sequencing data from 14 MB patients spanning all subgroups that we complemented with publicly available single-cell data from Group 3 patients. We used a ligand-receptor analysis tool (CellChat), expression- and allele-based copy-number variation (CNV) detection methods, and RNA velocity analysis to characterize tumor cell-cell interactions, established a connection between CNVs and temporal tumor progression, and unraveled tumor evolution.
Results:
We show that MB tumor cells follow a temporal trajectory from those with low CNV levels to those with high CNV levels, allowing us to identify early and late markers for SHH, Group 3, and Group 4 MBs. Our study also identifies SOX4 upregulation as a major event in later tumor clones for Group 3 and Group 4 MBs, suggesting it as a potential therapeutic target for both subgroups.
Conclusion:
Taken together, our findings highlight MB's inherent tumor heterogeneity and offer promising insights into potential drivers of MB tumor evolution particularly in Group 3 and Group 4 MBs.
Insights
Medulloblastoma tumor cells evolve along a trajectory marked by copy number variations (CNVs). Upregulation of SOX4 is identified as a key event in Group 3 and Group 4 medulloblastoma, offering a potential therapeutic target.
Area of Science:
- Oncology
- Genomics
- Pediatric Neuro-oncology
Background:
- Medulloblastoma (MB) is the most common pediatric brain tumor, with Group 3 and Group 4 subgroups being poorly characterized.
- High inter- and intratumoral heterogeneity in MB hinders the identification of therapeutic targets.
- Group 3 MB has a poor prognosis (~50% survival), while Group 4 is the most prevalent.
Purpose of the Study:
- To characterize cell-cell interactions, tumor progression, and evolution in medulloblastoma.
- To identify potential therapeutic targets for Group 3 and Group 4 medulloblastoma.
- To unravel the tumor evolutionary trajectory linked to copy number variations (CNVs).
Main Methods:
- Single-cell RNA sequencing data from 14 MB patients and public datasets.
- Ligand-receptor analysis using CellChat.
- Copy-number variation (CNV) detection and RNA velocity analysis.
Main Results:
- Medulloblastoma tumor cells exhibit a temporal progression from low to high CNV levels.
- Early and late molecular markers were identified for sonic-hedgehog (SHH), Group 3, and Group 4 MBs.
- SOX4 upregulation was identified as a significant event in later tumor clones of Group 3 and Group 4 MBs.
Conclusions:
- Medulloblastoma displays significant tumor heterogeneity and complex evolutionary dynamics.
- SOX4 is a potential therapeutic target for Group 3 and Group 4 medulloblastoma.
- Understanding tumor evolution provides insights into MB progression and potential treatment strategies.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:23Abnormal Proliferation
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...